NON-CYSTIC FIBROSIS BRONCHIECTASIS

This study is testing whether a home medical device called SIMEOX, used with remote guidance from a physical therapist, can help people with a chronic lung disease called bronchiectasis. The goal is to see if this approach improves patients' quality of life and reduces the number…

This study is testing whether an inhaled medicine called ensifentrine can help control a chronic lung disease called bronchiectasis. About 180 adults with this condition will use a nebulizer twice daily for at least 24 weeks, receiving either the real medicine or a placebo. The m…

This study is testing a new inhaled drug called GDC-6988 to see if it is safe and can help people with chronic lung diseases where thick mucus builds up. It will involve about 128 adults with conditions like COPD or bronchiectasis. Researchers will measure how the drug affects mu…

This study is testing a new inhaled antibody treatment called CSL787 for adults with non-cystic fibrosis bronchiectasis, a chronic lung condition. The main goal is to see if the treatment can delay or reduce the frequency of sudden worsening of symptoms, known as exacerbations, a…

This study is testing whether a home-based breathing training program, supported by a health coach, can help people with non-cystic fibrosis bronchiectasis. Researchers want to see if the training improves how far participants can walk, how well their lungs work, and their overal…

This study aims to better understand a chronic lung disease called non-cystic fibrosis bronchiectasis (NCFBE) in Chinese patients. Researchers will observe 320 participants, including people with the disease and healthy volunteers, to identify patterns in their symptoms and biolo…

This is a very early study to check if a new oral drug called RSS0343 is safe for people. Researchers are giving it to 48 healthy volunteers to see what side effects occur and how the body absorbs and eliminates it. The main goal is to gather basic safety information before testi…